Old Web
English
Sign In
Acemap
>
authorDetail
>
Roland W. Bürli
Roland W. Bürli
Charles River Laboratories
Pharmacology
In vivo
Histone deacetylase
Hydroxamic acid
Biology
4
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
2018
Bioorganic & Medicinal Chemistry Letters
Christopher A. Luckhurst
Omar Aziz
Vahri Beaumont
Roland W. Bürli
Perla Breccia
Michel Maillard
Alan Findlay Haughan
Marieke Lamers
Phil Leonard
Kim Matthews
Gilles Raphy
Andrew J. Stott
Ignacio Munoz-Sanjuan
Beth Thomas
Michael Wall
Grant Wishart
Dawn Yates
Celia Dominguez
Show All
Source
Cite
Save
Citations (12)
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
2012
PLOS ONE
Maria Beconi
Omar Aziz
Kim Matthews
Lara Moumné
Catherine O'Connell
Dawn Yates
Steven Clifton
Hannah Pett
Julie Vann
Lynsey Crowley
Alan Findlay Haughan
Donna L. Smith
Ben Woodman
Gillian P. Bates
Fred Brookfield
Roland W. Bürli
George McAllister
Celia Dominguez
Ignacio Munoz-Sanjuan
Vahri Beaumont
Show All
Source
Cite
Save
Citations (31)
Development of small-molecule therapies for autoimmune diseases
2010
Autoimmunity
Roland W. Bürli
Alan Findlay Haughan
Alastair J. Hodges
Show All
Source
Cite
Save
Citations (7)
Selective β-Hydroxyethylation at the N-1 Position of a Pyrazolone: Synthesis of Benzyl 1-(β-Hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxylate
2008
Synlett
Aaron C. Siegmund
Daniel Retz
Ning Xi
Celia Dominguez
Roland W. Bürli
Longbin Liu
Show All
Source
Cite
Save
Citations (1)
1